These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 21442130

  • 1. Overexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis.
    Uddin S, Jehan Z, Ahmed M, Alyan A, Al-Dayel F, Hussain A, Bavi P, Al-Kuraya KS.
    Mol Med; 2011; 17(7-8):635-45. PubMed ID: 21442130
    [Abstract] [Full Text] [Related]

  • 2. HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma.
    Bu R, Uddin S, Bavi P, Hussain AR, Al-Dayel F, Ghourab S, Ahmed M, Al-Kuraya KS.
    Lab Invest; 2011 Jan; 91(1):124-37. PubMed ID: 20661229
    [Abstract] [Full Text] [Related]

  • 3. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers.
    Uddin S, Siraj AK, Al-Rasheed M, Ahmed M, Bu R, Myers JN, Al-Nuaim A, Al-Sobhi S, Al-Dayel F, Bavi P, Hussain AR, Al-Kuraya KS.
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4088-97. PubMed ID: 18682509
    [Abstract] [Full Text] [Related]

  • 4. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
    Liu M, Bamodu OA, Huang WC, Zucha MA, Lin YK, Wu ATH, Huang CC, Lee WH, Yuan CC, Hsiao M, Deng L, Tzeng YM, Yeh CT.
    Toxicol Appl Pharmacol; 2017 Jun 15; 325():48-60. PubMed ID: 28408137
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.
    Zhang N, Qiu J, Zheng T, Zhang X, Hua K, Zhang Y.
    Oncol Rep; 2018 Mar 15; 39(3):1034-1042. PubMed ID: 29286125
    [Abstract] [Full Text] [Related]

  • 8. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids.
    Ziske MA, Pettee KM, Khaing M, Rubinic K, Eisenmann KM.
    Biochem Biophys Res Commun; 2016 Mar 25; 472(1):33-9. PubMed ID: 26898799
    [Abstract] [Full Text] [Related]

  • 9. Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer.
    Bauerschlag DO, Maass N, Leonhardt P, Verburg FA, Pecks U, Zeppernick F, Morgenroth A, Mottaghy FM, Tolba R, Meinhold-Heerlein I, Bräutigam K.
    J Transl Med; 2015 May 07; 13():146. PubMed ID: 25947066
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancer.
    Dai Y, Jin S, Li X, Wang D.
    Oncotarget; 2017 Jan 03; 8(1):1354-1368. PubMed ID: 27935869
    [Abstract] [Full Text] [Related]

  • 13. Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer.
    Uddin S, Ahmed M, Hussain A, Assad L, Al-Dayel F, Bavi P, Al-Kuraya KS, Munkarah A.
    Int J Cancer; 2010 Jan 15; 126(2):382-94. PubMed ID: 19621391
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
    Gaikwad SM, Thakur B, Sakpal A, Singh RK, Ray P.
    Int J Biochem Cell Biol; 2015 Apr 15; 61():90-102. PubMed ID: 25681684
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
    Liu YB, Mei Y, Tian ZW, Long J, Luo CH, Zhou HH.
    Cell Physiol Biochem; 2018 Apr 15; 46(5):1971-1984. PubMed ID: 29719287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.